静脉注射用免疫球蛋白在儿童血液/肿瘤性疾病中应用的儿科专家共识  

Pediatric expert consensus on the application of intravenous immunoglobulin in children with hematological/neoplastic diseases

作　　者：广东省医师协会儿科医师分会 《中国当代儿科杂志》编辑部 文飞球[2] 刘四喜[2] Pediatric Branch of Guangdong Medical Association;Editorial Department of Chinese Journal of Contemporary Pediatrics

机构地区：[1]不详 [2]深圳市儿童医院

出　　处：《中国当代儿科杂志》2021年第4期319-327,共9页Chinese Journal of Contemporary Pediatrics

摘　　要：静脉注射用免疫球蛋白(IVIG)在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍,但国内外尚无儿童血液/肿瘤性疾病中IVIG应用的临床指南或共识。该共识基于儿童血液/肿瘤性疾病中IVIG应用的国内外研究进展而制定,对IVIG在儿童血液/肿瘤性疾病中的临床应用策略及其不良反应的防治提出具体建议。Intravenous immunoglobulin(IVIG) has been widely used in chemotherapy for hematological malignancies, targeted therapy, and hematopoietic stem cell transplantation;however, there are still no available guidelines or consensus statements on the application of IVIG in pediatric hematological/neoplastic diseases at present in China and overseas. This consensus is developed based on the research advances in the application of IVIG in pediatric hematological/neoplastic diseases across the world and provides detailed recommendations for the clinical application of IVIG in pediatric hematological/neoplastic diseases and the prevention and treatment of related adverse reactions.

关 键 词：血液病 肿瘤性疾病 静脉注射用免疫球蛋白 专家共识 儿童 

分 类 号：R725.5[医药卫生—儿科]